Key facts
- Lyrebird Health’s last known valuation is $18.7M (May 2025).
- It has raised $7.9M; the latest was Early Stage VC ($7.8M) in May 2025.
- Notable investors include Octopus Ventures, Startmate, Five V Capital, Horizon Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Lyrebird Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Lyrebird Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lyrebird Health
Develoepr of an AI-driven healthcare documentation platform designed for clinical note generation. The company's platform listens to patient consultations, transcribes conversations into structured medical notes, enabling healthcare providers to streamline workflows, reduce administrative burden, and improve patient interaction efficiency.
- Sector
- Healthcare
- HQ
- Melbourne, Australia
- Founded
- 2023
- Employees
- 45
- Website
- lyrebirdhealth.com/
- Ownership
- Privately Held (backing)
Lyrebird Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lyrebird Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lyrebird Health in its N-PORT filings yet. We sweep new filings monthly.